Abstract
People who are structurally disadvantaged and marginalized often report poor health care experiences due to intersecting forms of stigma and discrimination. There are many measures of patient experiences of care, however, few are designed to measure equity-oriented care. In alignment with ongoing calls to integrate actions in support of health equity, we report on the development and testing of patient experiences of care measures that explicitly use a health equity and intersectional lens. Our analysis focuses on two different equity-oriented health care scales. The first was piloted in a primary health care setting, where patients have an ongoing relationship with providers over time. The second was piloted in an emergency department, where care is provided on an episodic basis. Item Response Theory was used to develop the scales and evaluate their psychometric properties. The primary health care scale, tested with a cohort of 567 patients, showed that providing more equity-oriented health care predicted improvements in important patient self-report health outcomes over time. The episodic scale, tested in an emergency department setting with 284 patients, showed evidence of concurrent validity, based on a high correlation with quality of care. Both scales are brief, easy-to-administer self-report measures that can support organizations to monitor quality of care using an equity lens. The availability of both scales enhances the possibility of measuring equity-oriented health care in diverse contexts. Both scales can shed light on experiences of care using an intersectional lens and equity-oriented lens, providing a nuanced understanding of quality of care.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Clinical Trials.gov #NCT03369678 (registration date November 18, 2017).
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol has been approved by the research ethics boards of the University of British Columbia, the University of Northern British Columbia, and the research ethics boards of Fraser Health Authority, Northern Health Authority, and Providence Health Care (approval #s H16–03397, H17–01548, and H18–01423).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The datasets generated and/or analyzed during the current study are not publicly available because we are still actively working on analyses, but are available from the corresponding author on reasonable request.
